Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction.

MLA

Turchetti, Giuseppe, et al. “Treat-to-Target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations. Introduction.” Clinical and Experimental Rheumatology, vol. 30, no. 4 Suppl 73, July 2012, p. S1. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23168235&authtype=sso&custid=ns315887.

APA

Turchetti, G., Smolen, J. S., Kavanaugh, A., Braun, J., Pincus, T., & Bombardieri, S. (2012). Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction. Clinical and Experimental Rheumatology, 30(4 Suppl 73), S1.

Chicago

Turchetti, Giuseppe, Josef S Smolen, Arthur Kavanaugh, Jurgen Braun, Ted Pincus, and Stefano Bombardieri. 2012. “Treat-to-Target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations. Introduction.” Clinical and Experimental Rheumatology 30 (4 Suppl 73): S1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23168235&authtype=sso&custid=ns315887.